首页|纳米粒-水凝胶复合递药系统在肿瘤治疗中的研究进展

纳米粒-水凝胶复合递药系统在肿瘤治疗中的研究进展

扫码查看
水凝胶和纳米颗粒在药物递送方面具有极大的应用前景。水凝胶具有良好的生物相容性以及物理化学的多功能性,可以实现疾病触发的原位自组装和药物持续性或响应性释放。纳米颗粒的高靶向性和低毒性可显著提高抗肿瘤药物的递送效率。然而,水凝胶和纳米颗粒在应用时仍面临诸多挑战,例如水凝胶具有机械强度低和难以递送疏水性药物等缺点,纳米颗粒具有脱靶效应以及在肿瘤的低蓄积和低滞留等问题。因此,将纳米颗粒掺入到水凝胶网络中可形成一种新型的多功能系统,使水凝胶成为抗肿瘤纳米药物局部应用的储库,从而结合两种制剂的优势以产生协同治疗效果。本文综述了纳米粒-水凝胶复合递药系统的药物释放行为设计,并概述了纳米粒-水凝胶复合递药系统在抗肿瘤药物局部应用方面的研究进展,包括瘤内和瘤周注射、皮下或肌肉注射、透皮给药和腔道内给药,为抗肿瘤新剂型和新制剂的设计提供思路和参考。
Recent Advances of Nanoparticle-Hydrogel Composite Drug Delivery Systems in Cancer Treatment
Hydrogels and nanoparticles have great application prospects in drug delivery.Hydrogels possess good biocompatibility and physicochemical versatility to enable disease-triggered in situ self-assemble and sustained or stimuli-responsive drug release.The high targeting ability and low toxicity of nanoparticles can significantly improve the delivery efficiency of antitumor drugs.However,hydrogels and nanoparticles still face many challenges in their applications,for example,hydrogels suffer from low mechanical strength and have difficulty in delivering hydrophobic drugs,while nanoparticles have off-target effects and low accumulation and retention in tumors.Therefore,the incorporation of nanoparticles into the hydrogel network can form a novel multifunctional system that enables the hydrogel to serve as a reservoir for the local delivery of nano-drugs into tumors,thereby combining the advantages of two preparations to produce synergistic therapeutic effects.Herein,we review the design of drug release behavior of nanoparticle-hydrogel composite sys-tems,and outline the recent progress of nanoparticle-hydrogel composite systems in the local application of antitumor drugs,including intratumoral and peritumoral injections,subcutaneous or intramuscular injections,transdermal administration and intraluminal adminis-tration,providing insights and references for the rational design of novel anti-tumor dosage forms and preparations.

nanoparticlehydrogelcomposite drug delivery systemtumorlocal treatment

唐海玉、李萌、袁志翔、何黎黎、韩露

展开 >

西南民族大学药学院,成都 610225

纳米粒 水凝胶 复合递药系统 肿瘤 局部治疗

国家自然科学基金中央高校基本科研业务费专项西南民族大学项目西南民族大学研究生创新型科学项目

82003683校20211050ZD2022220

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(10)
  • 126